Monthly Archives: May 2010

New weight loss pill promises to fight high blood pressure, diabetes

Posted on May 19, 2010 by

by JEAN ENERSEN / KING 5 News Posted on May 19, 2010 at 5:45 PM Excessive weight gain isn’t only unhealthy, it’s expensive. Nearly 10 percent of U.S. healthcare dollars are spent on obesity-related expenses. That’s why there’s so much … Continue reading →

Posted in Qnexa Articles | Tagged , , , , , , , , | Leave a comment

Data on VIVUS’ Qnexa to be Featured at World Congress Highlighting Metabolic Disease and Related Disorders

Posted on May 13, 2010 by

MOUNTAIN VIEW, Calif., May 13 /PRNewswire-FirstCall/ — VIVUS, Inc. (Nasdaq: VVUS) today announced that data on Qnexa®, an investigational drug candidate, will be presented at the 3rd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) in Prague, Czech Republic. Timothy Garvey, … Continue reading →

Posted in News | Tagged , , , , | Leave a comment

Motley Fool lists VIVUS as 1 of 5 Stocks Breaking Out

Posted on May 10, 2010 by

Excerpt from Motley Fool Article VIVUS has a lot riding on its obesity drug Qnexa, which has potentially huge profit potential due to the size (sorry) of its target market. Along with competitor Arena Pharmaceuticals (Nasdaq: ARNA) — who is … Continue reading →

Posted in Finance | Tagged , , | Leave a comment

Qnexa Suppresses Appetite, Lowers Blood Pressure in Study

Posted on May 5, 2010 by

By Denise Mann WebMD Health News// // ]]> May 4, 2010 (New York) — An experimental weight loss/blood pressure pill may pack a one-two punch against hunger and high blood pressure, one of the main health consequences of obesity, according to new … Continue reading →

Posted in News | Tagged , , , , , , , , , | Leave a comment

VIVUS Reports First Quarter 2010 Financial Results

Posted on May 3, 2010 by

// // // ]]> MOUNTAIN VIEW, Calif., May 3, 2010 /PRNewswire via COMTEX/ — VIVUS, Inc. (10.71, -0.04, -0.37%), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today reported its highlights and financial results for the first quarter … Continue reading →

Posted in News | Tagged , , , , , , , , , | Leave a comment